stella
beta
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications — Stella
Recruiting
Back to Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, or Other Conditions for Which Risankizumab is an FDA-approved Treatment trials
Trial locations
(2 sites)
United States
Evidera, a PPD Business Unit /ID# 238688, Morrisville, North Carolina
PPD Development, LP /ID# 232134, Wilmington, North Carolina
View full record on ClinicalTrials.gov